Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04May 09, 2022
License Agreement
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of RSV Vaccine for Adults in China
Nuance Pharma
PR-M03-22-08Mar 21, 2022
License Agreement
Confirmation That the License to Develop Oral Vaccine Delivery Platform Has Been Executed
Poolbeg Pharma PLC
PR-M01-22-22Jan 31, 2022
Licensing
Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases
Corbus
PR-M06-21-009Jun 07, 2021
Licensing Agreement
Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder
Massachusetts Eye and Ear
PR-M07-20-NI-001Jul 03, 2020
Agreement
Hansa Biopharma Announces Exclusive Agreement with Sarepta Therapeutics to Develop Imlifidase as Pre-treatment Ahead of Gene Therapy
Sarepta Therapeutics, Inc
PR-M07-20-NI-004Jul 03, 2020
Licensing
Ionis Licenses Hepatitis B Program to GSK
Ionis Pharmaceuticals, Inc.
PR-M08-19-NI-085Aug 29, 2019
License Agreement
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss
Astellas
PR-M07-19-NI-055Jul 22, 2019
Licensing
Prestige Biopharma and Pharmapark Announce License and Supply Agreement to Commercialize Prestige's Trastuzumab Biosimilar in the Russian Federation
Prestige BioPharma
PR-M07-19-NI-021Jul 09, 2019
Licensing
argenx Licenses Halozyme Subcutaneous Delivery Tech
Nice Insight
PAO-M02-19-NI-002Feb 05, 2019
License Agreement
Ablexis Announces Licensing Agreement with Allogene Therapeutics
Ablexis, LLC
PR-M12-18-NI-026Dec 10, 2018
Agreement
REGENXBIO and Rocket Pharmaceuticals Announce New License Agreement for the Treatment of Danon Disease Using NAV AAV9 Vector
REGENXBIO
PR-M11-18-NI-108Nov 30, 2018
Investment
Kaneka has invested in AB-Biotics SA, a Spanish biotech company and concluded a license agreement for production and sales of its probiotics products
Kaneka
PR-M05-18-NI-067May 17, 2018